Matsuo Koji, Garcia-Sayre Jocelyn, Medeiros Fabiola, Casabar Jennifer K, Machida Hiroko, Moeini Aida, Roman Lynda D
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California.
Norris Comprehensive Cancer Center, University of Southern California, California.
J Surg Oncol. 2015 Nov;112(6):669-76. doi: 10.1002/jso.24049. Epub 2015 Sep 22.
BACKGROUND AND OBJECTIVES: To determine the significance of depth and extent of lymphovascular space invasion (LVSI) on lymph node metastasis and recurrence in endometrial cancer. METHODS: A case-control study was conducted to examine LVSI-positive (n = 70) and LVSI-negative (n = 641) stage I-III endometrial cancer cases that underwent hysterectomy-based surgical staging. The risk of lymph node metastasis and distant recurrence was estimated based on LVSI patterns. RESULTS: In multivariate analysis, deep (>50% invasion), and extensive (≥7 foci/slide) LVSI patterns had a significantly increased risk of lymph node metastasis (incidence 57.6% and 72.7%, odds ratio 33.8 and 49.9, respectively, P < 0.001) as compared to other traditional uterine factors (>50% myometrial tumor invasion, cervical stromal invasion, and adnexal involvement: incidence range 30.4-37.9%, odds ratio range 3.80-7.03). Deep and extensive of LVSI patterns were both significantly correlated to distant recurrence (P < 0.001). Among women who received postoperative chemotherapy, deep and extensive LVSI patterns did not have increased risks for distant recurrence compared to no LVSI (P = 0.47 and 0.32, respectively). Among women who received postoperative radiotherapy, the depth of LVSI was significantly associated with recurrence outside the radiated field (P = 0.02). CONCLUSIONS: Depth and extent of LVSI are important predictors for lymph node metastasis and distant recurrence in endometrial cancer.
Asian Pac J Cancer Prev. 2015
Int J Gynecol Cancer. 2015-1
Aust N Z J Obstet Gynaecol. 2013-6
Int J Gynecol Cancer. 2014-7
Acta Obstet Gynecol Scand. 2000-4
JAMA Netw Open. 2024-3-4
Int J Mol Sci. 2022-3-18
CA Cancer J Clin. 2015-1-5
Gynecol Oncol. 2014-12-10
Ann Surg Oncol. 2014-12